Stryker Corp (SYK)
332.25
+6.75
(+2.07%)
USD |
NYSE |
May 07, 16:00
332.25
0.00 (0.00%)
After-Hours: 16:21
Stryker Research and Development Expense (TTM): 1.417B for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.417B |
| December 31, 2023 | 1.388B |
| September 30, 2023 | 1.364B |
| June 30, 2023 | 1.375B |
| March 31, 2023 | 1.38B |
| December 31, 2022 | 1.454B |
| September 30, 2022 | 1.459B |
| June 30, 2022 | 1.401B |
| March 31, 2022 | 1.36B |
| December 31, 2021 | 1.235B |
| September 30, 2021 | 1.159B |
| June 30, 2021 | 1.095B |
| March 31, 2021 | 1.018B |
| December 31, 2020 | 984.00M |
| September 30, 2020 | 983.00M |
| June 30, 2020 | 987.00M |
| March 31, 2020 | 1.00B |
| December 31, 2019 | 971.00M |
| September 30, 2019 | 938.00M |
| June 30, 2019 | 913.00M |
| March 31, 2019 | 883.00M |
| December 31, 2018 | 862.00M |
| September 30, 2018 | 846.00M |
| June 30, 2018 | 823.00M |
| March 31, 2018 | 799.00M |
| Date | Value |
|---|---|
| December 31, 2017 | 787.00M |
| September 30, 2017 | 771.00M |
| June 30, 2017 | 757.00M |
| March 31, 2017 | 748.00M |
| December 31, 2016 | 715.00M |
| September 30, 2016 | 690.00M |
| June 30, 2016 | 661.00M |
| March 31, 2016 | 632.00M |
| December 31, 2015 | 625.00M |
| September 30, 2015 | 614.00M |
| June 30, 2015 | 612.00M |
| March 31, 2015 | 616.00M |
| December 31, 2014 | 614.00M |
| September 30, 2014 | 600.00M |
| June 30, 2014 | 583.00M |
| March 31, 2014 | 557.00M |
| December 31, 2013 | 536.00M |
| September 30, 2013 | 526.00M |
| June 30, 2013 | 504.00M |
| March 31, 2013 | 488.00M |
| December 31, 2012 | 471.00M |
| September 30, 2012 | 457.00M |
| June 30, 2012 | 465.00M |
| March 31, 2012 | 463.00M |
| December 31, 2011 | 462.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
913.00M
Minimum
Jun 2019
1.459B
Maximum
Sep 2022
1.194B
Average
1.197B
Median
Research and Development Expense (TTM) Benchmarks
| Boston Scientific Corp | 1.444B |
| Haemonetics Corp | 54.22M |
| Abbott Laboratories | 2.771B |
| Zimmer Biomet Holdings Inc | 456.20M |
| ResMed Inc | 304.81M |